Supplemental material
Research Article
Alpha1-antitrypsin impacts innate host–pathogen interactions with Candida albicans by stimulating fungal filamentation
Martin Jaegera Department of Medicine, University of Colorado Denver, Aurora, USA;b Department of Internal Medicine, Radboud University Medical Center and Radboud Center for Infectious diseases (RCI), Nijmegen, the Netherlands
https://orcid.org/0000-0001-6994-493XView further author information
https://orcid.org/0000-0001-6994-493XView further author information, Axel Dietschmannc Junior Research Group Adaptive Pathogenicity Strategies, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute, Jena, Germanyhttps://orcid.org/0000-0002-0598-9714View further author information
https://orcid.org/0000-0002-0598-9714View further author information, Sophie Austermeierd Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute, Jena, Germanyhttps://orcid.org/0000-0002-1048-5983View further author information
https://orcid.org/0000-0002-1048-5983View further author information, Sude Dinçerc Junior Research Group Adaptive Pathogenicity Strategies, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute, Jena, Germanyhttps://orcid.org/0009-0001-8671-309XView further author information
https://orcid.org/0009-0001-8671-309XView further author information, Pauline Porschitzc Junior Research Group Adaptive Pathogenicity Strategies, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute, Jena, Germanyhttps://orcid.org/0000-0003-4776-0325View further author information
https://orcid.org/0000-0003-4776-0325View further author information, Larsen Vornholze Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germanyhttps://orcid.org/0000-0002-8054-5603View further author information
https://orcid.org/0000-0002-8054-5603View further author information, , , Jürgen Rulande Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany;i German Cancer Consortium (DKTK), partner site Munich, Germany;j German Center for Infection Research (DZIF), partner site Munich, Germanyhttps://orcid.org/0000-0002-8381-3597View further author information
https://orcid.org/0000-0002-8381-3597View further author information, Stefan Wirtzg Medizinische Klinik 1, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germanyhttps://orcid.org/0000-0001-6936-7431View further author information
https://orcid.org/0000-0001-6936-7431View further author information, , , Bernhard Hubed Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute, Jena, Germany;h Institute of Microbiology, Friedrich-Schiller-University, Jena, Germanyhttps://orcid.org/0000-0002-6028-0425View further author information
https://orcid.org/0000-0002-6028-0425View further author information, , & Mark S. Gresnigta Department of Medicine, University of Colorado Denver, Aurora, USA;c Junior Research Group Adaptive Pathogenicity Strategies, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute, Jena, GermanyCorrespondence[email protected]
https://orcid.org/0000-0002-9514-4634View further author information
https://orcid.org/0000-0002-9514-4634View further author information show all